← Actis Oncology clinical programs
What podcasts say about Actis Oncology clinical programs
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Actis Oncology clinical programs
1 statement · 1 neutral
Actis expects initial data from its Nectin4 and B7H3 programs in 2027
“publicly guided to initial clinical data in both of these lead programs in 2027”
Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades LiveListen at 32:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.